[1] |
Bahn RS. Graves′ ophthalmopathy[J]. N Engl J Med,2010,362:726-738.
|
[2] |
Naik V, Khadavi N, Naik MN, et al. Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy[J]. Thyroid,2008,18:967-971.
|
[3] |
Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves′ ophthalmopathy: a novel approach[J]. Br J Ophthalmol,1989, 73:639-644.
|
[4] |
Witten DM TR. A comparison of fold-change and the t-statistic for microarray data analysis[D]. Palo Alto: Stanford University,2007:1-13.
|
[5] |
Nguyen B, Gopinath B, Tani J, et al. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves′ ophthalmopathy[J]. Autoimmunity,2008, 41:372-376.
|
[6] |
Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans[J]. Science,2001,294:858-862.
|
[7] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell,2004,116:281-297.
|
[8] |
Liu R, Ma X, Xu L, et al. Differential microRNA expression in peripheral blood mononuclear cells from Graves′ disease patients[J]. J Clin Endocrinol Metab,2012,97:E968-972.
|
[9] |
Git A, Dvinge H, Salmon-Divon M, et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression[J]. RNA,2010,16:991-1006.
|
[10] |
Xu G, Wu J, Zhou L, et al. Characterization of the small RNA transcriptomes of androgen dependent and independent prostate cancer cell line by deep sequencing[J]. PLoS One,2010,5:e15519.
|
[11] |
Ishida W, Fukuda K, Higuchi T, et al. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis[J]. Invest Ophthalmol Vis Sci,2011, 52:611-617.
|
[12] |
Pedersen I, David M. MicroRNAs in the immune response[J]. Cytokine,2008,43:391-394.
|
[13] |
Gantier MP, Stunden HJ, McCoy CE, et al. A miR-19 regulon that controls NF-?资appaB signaling[J]. Nucleic Acids Res,2012,40:8048-8058.
|
[14] |
Gantier MP. X-chromosome-encoded microRNA-19 and -18 are possible modulators of female immunity[J]. Bioessays,2013,35:671.
|
[15] |
Gupta MK, Halley C, Duan ZH, et al. miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients[J]. J Mol Cell Cardiol,2013,62:131-141.
|
[16] |
Byrd AE, Aragon IV, Brewer JW. MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response[J]. J Cell Biol,2012,196:689-698.
|
[17] |
钟河江,杨天德. 内质网应激与免疫炎症反应的研究进展[J]. 重庆医学,2012:201-203+206.
|
[18] |
Taganov KD, Boldin MP, Chang KJ, et al. NF-?资appaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses[J]. Proc Natl Acad Sci USA,2006,103:12481-12486.
|
[19] |
杨文娟,班胜刚,何剑峰. 甲状腺相关眼病患者外周血单个核细胞中微小RNA-146a的异常表达及意义[J]. 眼科新进展,2012:414-417.
|